Reporte zur Charge Z1A024N

Symptomtext

Opened IPOL MDV at a high of 47.5F out of range for 20 minutes with no reported adverse event; Initial information received on 18-Jul-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 5 years old male patient who experienced opened ipol mdv at a high of 47.5f out of range for 20 minutes with no reported adverse event while receiving vaccine IPV (VERO) [IPOL]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DTAP), HEPATITIS A VACCINE (HEPATITIS A, MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR) for Immunisation and VARICELLA ZOSTER VACCINE (VARICELLA VACCINE) all for Immunisation. On 15-Jul-2022, the patient received a 0.5 ml dose of suspect IPV (VERO) vaccine once (lot Z1A024N; expiry date: 17-Feb-2024) via intramuscular route in the left thigh for immunization. On an unknown date the patient reported opened ipol mdv at a high of 47.5f out of range for 20 minutes with no reported adverse event (product storage error) (unknown latency) following the administration of IPV (VERO). Action taken :not applicable. At time of reporting, the outcome was Unknown for the event opened ipol mdv at a high of 47.5f out of range for 20 minutes with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.